Factors related to HIV-associated neurocognitive impairment differ with age

Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69(18):1789–1799. doi:10.1212/01.WNL.0000287431.88658.8b Atkinson JH, Heaton RK, Patterson TL, Wolfson T, Deutsch R, Brown SJ, Summers J, Sciolla A, Gutierrez R, Ellis RJ, Abramson I, Hesselink JR, McCutchan JA, Grant I (2008) Two-year prospective study of major depressive disorder in HIV-infected men. J Affect Disord 108(3):225–234. doi:10.1016/j.jad.2007.10.017 Bandaru VV, Mielke MM, Sacktor N, McArthur JC, Grant I, Letendre S, Chang L, Wojna V, Pardo C, Calabresi P, Munsaka S, Haughey NJ (2013) A lipid storage-like disorder contributes to cognitive decline in HIV-infected subjects. Neurology 81(17):1492–1499. doi:10.1212/WNL.0b013e3182a9565e Battery AIT (1944) Manual of directions and scoring. Adjunctant General’s Office, Washington Beck AT, Steer RA, Brown GK (1996) Manual for the Beck Depression Inventory-II. Psychological Corporation, San Antonio Becker JT, Kingsley L, Mullen J, Cohen B, Martin E, Miller EN, Ragin A, Sacktor N, Selnes OA, Visscher BR (2009) Vascular risk factors, HIV serostatus, and cognitive dysfunction in gay and bisexual men. Neurology 73(16):1292–1299. doi:10.1212/WNL.0b013e3181bd10e7 Becker JT, Dew MA, Aizenstein HJ, Lopez OL, Morrow L, Saxton J (2011) Concurrent validity of a computer-based cognitive screening tool for use in adults with HIV disease. AIDS Patient Care STDS 25(6):351–357. doi:10.1089/apc.2011.0051 Benedict RH, Schretlen D, Groningger L, Dobraski M (1996) Revision of the brief visuospatial memory test: studies of normal performance, reliability, and validity. Psychol Assess 8(2):145–153 Bernstein LE, Berry J, Kim S, Canavan B, Grinspoon SK (2006) Effects of etanercept in patients with the metabolic syndrome. Arch Intern Med 166(8):902–908. doi:10.1001/archinte.166.8.902 Bottiggi KA, Chang JJ, Schmitt FA, Avison MJ, Mootoor Y, Nath A, Berger JR (2007) The HIV dementia scale: predictive power in mild dementia and HAART. J Neurol Sci 260(1–2):11–15. doi:10.1016/j.jns.2006.03.023 Burdo TH, Lo J, Abbara S, Wei J, DeLelys ME, Preffer F, Rosenberg ES, Williams KC, Grinspoon S (2011) Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients. J Infect Dis 204(8):1227–1236. doi:10.1093/infdis/jir520 Carey CL, Woods SP, Gonzalez R, Conover E, Marcotte TD, Grant I, Heaton RK (2004) Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol 26(3):307–319. doi:10.1080/13803390490510031 Carey CL, Woods SP, Rippeth JD, Gonzalez R, Heaton RK, Grant I (2006) Additive deleterious effects of methamphetamine dependence and immunosuppression on neuropsychological functioning in HIV infection. AIDS Behav 10(2):185–190. doi:10.1007/s10461-005-9056-4 Correia S, Cohen R, Gongvatana A, Ross S, Olchowski J, Devlin K, Tashima K, Navia B, Delamonte S (2013) Relationship of plasma cytokines and clinical biomarkers to memory performance in HIV. J Neuroimmunol 265(1–2):117–123. doi:10.1016/j.jneuroim.2013.09.005 Cross S, Onen N, Gase A, Overton ET, Ances BM (2013) Identifying risk factors for HIV-associated neurocognitive disorders using the international HIV dementia scale. J Neuroimmune Pharmacol 8(5):1114–1122. doi:10.1007/s11481-013-9505-1 Cysique LA, Brew BJ (2011) Prevalence of non-confounded HIV-associated neurocognitive impairment in the context of plasma HIV RNA suppression. J Neurovirol 17(2):176–183. doi:10.1007/s13365-011-0021-x Cysique LA, Murray JM, Dunbar M, Jeyakumar V, Brew BJ (2010) A screening algorithm for HIV-associated neurocognitive disorders. HIV Med 11(10):642–649. doi:10.1111/j.1468-1293.2010.00834.x Cysique LA, Maruff P, Bain MP, Wright E, Brew BJ (2011) HIV and age do not substantially interact in HIV-associated neurocognitive impairment. J Neuropsychiatry Clin Neurosci 23(1):83–89. doi:10.1176/appi.neuropsych.23.1.83 Dantzer R, Kelley KW (2007) Twenty years of research on cytokine-induced sickness behavior. Brain Behav Immun 21(2):153–160. doi:10.1016/j.bbi.2006.09.006 DSM-IV (2000) American psychiatric association: diagnostic and statistical manual of mental disorders. American Psychiatric Association, Washington Dwyer R, Wenhui L, Cysique L, Brew BJ, Lal L, Bain P, Wesselingh S, Wright EJ (2014) Symptoms of depression and rates of neurocognitive impairment in HIV positive patients in Beijing, China. J Affect Disord 162:89–95. doi:10.1016/j.jad.2014.03.038 Erlandson KM, Schrack JA, Jankowski CM, Brown TT, Campbell TB (2014) Functional impairment, disability, and frailty in adults aging with HIV-infection. Curr HIV/AIDS Rep. doi:10.1007/s11904-014-0215-y Everall I, Vaida F, Khanlou N, Lazzaretto D, Achim C, Letendre S, Moore D, Ellis R, Cherner M, Gelman B, Morgello S, Singer E, Grant I, Masliah E (2009) Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy. J Neurovirol 15(5–6):360–370. doi:10.3109/13550280903131915 Fialho RM, Pereira M, Mendonca N, Ouakinin S (2013) Depressive symptoms and neurocognitive performance among HIV-infected women. Women Health 53(2):117–134. doi:10.1080/03630242.2013.767301 Foley J, Ettenhofer M, Wright MJ, Siddiqi I, Choi M, Thames AD, Mason K, Castellon S, Hinkin CH (2010) Neurocognitive functioning in HIV-1 infection: effects of cerebrovascular risk factors and age. Clin Neuropsychol 24(2):265–285. doi:10.1080/13854040903482830 Gandhi NS, Moxley RT, Creighton J, Roosa HV, Skolasky RL, Selnes OA, McArthur J, Sacktor N (2010) Comparison of scales to evaluate the progression of HIV-associated neurocognitive disorder. HIV Ther 4(3):371–379. doi:10.2217/hiv.10.23 Gannon P, Khan MZ, Kolson DL (2011) Current understanding of HIV-associated neurocognitive disorders pathogenesis. Curr Opin Neurol 24(3):275–283. doi:10.1097/WCO.0b013e32834695fb Gaskill PJ, Calderon TM, Luers AJ, Eugenin EA, Javitch JA, Berman JW (2009) Human immunodeficiency virus (HIV) infection of human macrophages is increased by dopamine: a bridge between HIV-associated neurologic disorders and drug abuse. Am J Pathol 175(3):1148–1159. doi:10.2353/ajpath.2009.081067 Gongvatana A, Correia S, Devlin K, Dunsiger S, Ross S, Navia B et al. (2012) Clinical factors and plasma cytokine markers are related to brain volumes in HIV+ individuals. Paper presented at the 19th Conference on Retroviruses and Opportunistic Infections, Seattle, 5–8 March 2012 Haddow LJ, Floyd S, Copas A, Gilson RJ (2013) A systematic review of the screening accuracy of the HIV dementia scale and international HIV dementia scale. PLoS ONE 8(4):e61826. doi:10.1371/journal.pone.0061826 Hasin DS, Trautman KD, Miele GM, Samet S, Smith M, Endicott J (1996) Psychiatric research interview for substance and mental disorders (PRISM): reliability for substance abusers. Am J Psychiatry 153(9):1195–1201 Heaton RK, Marcotte TD, Mindt MR, Sadek J, Moore DJ, Bentley H, McCutchan JA, Reicks C, Grant I (2004) The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc 10(3):317–331. doi:10.1017/S1355617704102130S1355617704102130 Heaton RK, Clifford DB, Franklin DR Jr, Woods SP, Ake C, Vaida F, Ellis RJ, Letendre SL, Marcotte TD, Atkinson JH, Rivera-Mindt M, Vigil OR, Taylor MJ, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER study. Neurology 75(23):2087–2096. doi:10.1212/WNL.0b013e318200d727 Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, Leblanc S, Corkran SH, Duarte NA, Clifford DB, Woods SP, Collier AC, Marra CM, Morgello S, Mindt MR, Taylor MJ, Marcotte TD, Atkinson JH, Wolfson T, Gelman BB, McArthur JC, Simpson DM, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I (2011) HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol 17(1):3–16. doi:10.1007/s13365-010-0006-1 Herndier BG, Kaplan LD, McGrath MS (1994) Pathogenesis of AIDS lymphomas. AIDS 8(8):1025–1049 High KP, Brennan-Ing M, Clifford DB, Cohen MH, Currier J, Deeks SG, Deren S, Effros RB, Gebo K, Goronzy JJ, Justice AC, Landay A, Levin J, Miotti PG, Munk RJ, Nass H, Rinaldo CR Jr, Shlipak MG, Tracy R, Valcour V, Vance DE, Walston JD, Volberding P (2012) HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH office of AIDS research by the HIV and aging working group. J Acquir Immune Defic Syndr 60(Suppl 1):S1–S18. doi:10.1097/QAI.0b013e31825a3668 Kessler RC, Ustun TB (2004) The world mental health (WMH) survey initiative version of the world health organization (WHO) composite international diagnostic interview (CIDI). Int J Methods Psychiatr Res 13(2):93–121 Klove H (1963) Clinical neuropsychology. Med Clin N Am 47:1647–1658 Lamers SL, Fogel GB, Singer EJ, Salemi M, Nolan DJ, Huysentruyt LC, McGrath MS (2012) HIV-1 Nef in macrophage-mediated disease pathogenesis. Int Rev Immunol 31(6):432–450. doi:10.3109/08830185.2012.737073 Leserman J (2008) Role of depression, stress, and trauma in HIV disease progression. Psychosom Med 70(5):539–545. doi:10.1097/PSY.0b013e3181777a5f Levine AJ, Hardy DJ, Miller E, Castellon SA, Longshore D, Hinkin CH (2006) The effect of recent stimulant use on sustained attention in HIV-infected adults. J Clin Exp Neuropsychol 28(1):29–42. doi:10.1080/13803390490918066 Li C, Zhang X, Komery A, Li Y, Novembre FJ, Herndon JG (2011) Longitudinal diffusion tensor imaging and perfusion MRI investigation in a macaque model of neuro-AIDS: a preliminary study. Neuroimage 58(1):286–292. doi:10.1016/j.neuroimage.2011.05.068 Lo J, Bernstein LE, Canavan B, Torriani M, Jackson MB, Ahima RS, Grinspoon SK (2007) Effects of TNF-alpha neutralization on adipocytokines and skeletal muscle adiposity in the metabolic syndrome. Am J Physiol Endocrinol Metab 293(1):E102–E109. doi:10.1152/ajpendo.00089.2007 McCutchan A, Marquie-Beck J, FitzSimons C, Letendre S, Ellis R, Heaton RK et al. (2012) Role of central obesity, diabetes, and metabolic variables in HIV-associated neurocognitive disorder. Paper presented at the 19th Conference on Retroviruses and Opportunistic Infections, Seattle, WA, March 5–8, 2012 Meade CS, Conn NA, Skalski LM, Safren SA (2011) Neurocognitive impairment and medication adherence in HIV patients with and without cocaine dependence. J Behav Med 34(2):128–138. doi:10.1007/s10865-010-9293-5 Milanini B, Wendelken LA, Esmaeili-Firidouni P, Chartier M, Crouch PC, Valcour V (2014) The Montreal cognitive assessment to screen for cognitive impairment in HIV patients older than 60 years. J Acquir Immune Defic Syndr 67(1):67–70. doi:10.1097/QAI.0000000000000220 Morgello S, Gelman BB, Kozlowski PB, Vinters HV, Masliah E, Cornford M, Cavert W, Marra C, Grant I, Singer EJ (2001) The national NeuroAIDS tissue consortium: a new paradigm in brain banking with an emphasis on infectious disease. Neuropathol Appl Neurobiol 27(4):326–335 Morgello S, Holzer CE 3rd, Ryan E, Young C, Naseer M, Castellon SA, Frol AB, Atkinson JH, Gelman BB, Grant I, Singer EJ (2006) Interrater reliability of the psychiatric research interview for substance and mental disorders in an HIV-infected cohort: experience of the national NeuroAIDS tissue consortium. Int J Methods Psychiatr Res 15(3):131–138 Power C, Selnes OA, Grim JA, McArthur JC (1995) HIV dementia scale: a rapid screening test. J Acquir Immune Defic Syndr Hum Retrovirol 8(3):273–278 Raison CL, Capuron L, Miller AH (2006) Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 27(1):24–31. doi:10.1016/j.it.2005.11.006 Report of a Working Group of the American Academy of Neurology AIDS Task Force (1991) Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Neurology 41(6):778–785 Rippeth JD, Heaton RK, Carey CL, Marcotte TD, Moore DJ, Gonzalez R, Wolfson T, Grant I (2004) Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. J Int Neuropsychol Soc 10(1):1–14. doi:10.1017/S1355617704101021 Sacktor NC, Wong M, Nakasujja N, Skolasky RL, Selnes OA, Musisi S, Robertson K, McArthur JC, Ronald A, Katabira E (2005) The international HIV dementia scale: a new rapid screening test for HIV dementia. AIDS 19(13):1367–1374 Sacktor N, Skolasky R, Selnes OA, Watters M, Poff P, Shiramizu B, Shikuma C, Valcour V (2007) Neuropsychological test profile differences between young and old human immunodeficiency virus-positive individuals. J Neurovirol 13(3):203–209. doi:10.1080/13550280701258423 Schouten J, Cinque P, Gisslen M, Reiss P, Portegies P (2011) HIV-1 infection and cognitive impairment in the cART era: a review. AIDS 25(5):561–575. doi:10.1097/QAD.0b013e3283437f9a Shapiro AM, Benedict RH, Schretlen D, Brandt J (1999) Construct and concurrent validity of the Hopkins verbal learning test—revised. Clin Neuropsychol 13(3):348–358. doi:10.1076/clin.13.3.348.1749 Shapshak P, Kangueane P, Fujimura RK, Commins D, Chiappelli F, Singer E, Levine AJ, Minagar A, Novembre FJ, Somboonwit C, Nath A, Sinnott JT (2011) Editorial neuroAIDS review. AIDS 25(2):123–141. doi:10.1097/QAD.0b013e328340fd42 Shiramizu B, Ananworanich J, Chalermchai T, Siangphoe U, Troelstrup D, Shikuma C, De Grutolla V, Sithinamsuwan P, Praihirunkit P, Rattanamanee S, Valcour V (2011) Failure to clear intra-monocyte HIV infection linked to persistent neuropsychological testing impairment after first-line combined antiretroviral therapy. J Neurovirol. doi:10.1007/s13365-011-0068-8 Silverstein PS, Shah A, Weemhoff J, Kumar S, Singh DP, Kumar A (2012) HIV-1 gp120 and drugs of abuse: interactions in the central nervous system. Curr HIV Res 10(5):369–383 Smith CA, van Gorp WG, Ryan ER, Ferrando SJ, Rabkin J (2003) Screening subtle HIV-related cognitive dysfunction: the clinical utility of the HIV dementia scale. J Acquir Immune Defic Syndr 33(1):116–118 Wechsler D (1997) Wechsler Adult Intelligence Scale-III. The Psychological Corporation, San Antonio Wiens AN, Fuller KH, Crossen JR (1997) Paced auditory serial addition test: adult norms and moderator variables. J Clin Exp Neuropsychol 19(4):473–483. doi:10.1080/01688639708403737 Woods SP, Rippeth JD, Frol AB, Levy JK, Ryan E, Soukup VM, Hinkin CH, Lazzaretto D, Cherner M, Marcotte TD, Gelman BB, Morgello S, Singer EJ, Grant I, Heaton RK (2004) Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV. J Clin Exp Neuropsychol 26(6):759–778. doi:10.1080/13803390490509565 Yang SJ (2004) Hyperlipidemia and liver diseases. Hepatobiliary Pancreatol Dis Int 3(1):10–11 Zipursky AR, Gogolishvili D, Rueda S, Brunetta J, Carvalhal A, McCombe JA, Gill MJ, Rachlis A, Rosenes R, Arbess G, Marcotte T, Rourke SB (2013) Evaluation of brief screening tools for neurocognitive impairment in HIV/AIDS: a systematic review of the literature. AIDS 27(15):2385–2401. doi:10.1097/QAD.0b013e328363bf56